FDA expands indication for TAVR to low-risk patients

AM Show
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

ST. LOUIS – a new FDA ruling is expected to have a positive impact on many heart patients. The transcatheter aortic (aye-or-tick) valve implantation, was only available for high-risk patients allowing them to avoid open-heart surgery. Now the FDA ruling now allows the device for low-risk patients too.

Dr. Michael Lim Cardiologist with SLUCare and SSM Health Saint Louis University Hospital discusses how the device works and how the FDA ruling is a game-changer.

FOX 2 Newsletters

Sign up for a newsletter from FOX 2 to get updates about news and weather. We offer daily headlines, breaking news, severe weather, and forecast emails.


Latest News

More News